Backing science's boldest breakthroughs, a profile of Empirical Ventures
With #QVCs, Maddyness UK profiles different funds to give founders and entrepreneurs the information they need to choose the right investor. This week, we speak to Johnathan Matlock, cofounder of Empirical Ventures.
Read the article >
How could AI sovereignty give startups a competitive advantage?
In a turbulent economic landscape for startups, building trust is more important than ever. What is AI sovereignty and how can it help? Maddyness UK investigates.
Women still marginalised in Europe's Tech Ecosystem
Whether as startup founders or investors, women remain underrepresented in venture capital (VC) deals, as revealed by the latest Pitchbook report.
CuspAI, harnessing AI to unlock materials breakthroughs in months, not millennia
As part of our quick founder questions series – or QFQs – we spoke to Chad Edwards, cofounder and CEO of CuspAI about investment, material science and using AI to deliver meaningful change.
4 Startups to watch in the "Rearmament" of Europe
On the back of the European announcement to invest heavily in its military arsenal, Maddyness has identified four French and European startups that are playing a role in the defence sector.
Making a C-turn: What I learned switching C-suite roles
Last month, I got a new job. Except this didn’t come with the standard trappings of a fresh role - no new colleagues, changed commute, nor complicated coffee machine to contend with. Instead, I was taking on a new position in the organisation I co-founded and have helped lead for nearly a decade.
Are investment portfolios at risk due to R&D mis-claims?
HMRC’s R&D relief scheme exists to support fast-growing tech businesses, promote innovation among them, and ultimately make a significant contribution to the UK economy and GDP. However, the process has become more complex over time, with HMRC bringing in increasingly stringent rules and regulations to ensure the scheme is used correctly.
Habitual, the tools, support, and guidance you need to achieve and maintain better health
As part of our quick founder questions series – or QFQs – we spoke to Napala Pratini, CEO & cofounder of Habitual about habit change, weight loss and the reversal of type 2 diabetes.
AI-driven economic growth: Europe’s path to a Trillion-Euro boost
Recent reports suggest that generative AI alone could add between €1.2T and €1.4T to the European Union's GDP over the next decade. As Europe seeks to capitalise on this technological revolution, the question is not just about embracing AI but strategically integrating it to unlock maximum value. In this article we look at which sectors stand to gain the most, and what strategies will ensure Europe realises this trillion-euro opportunity?
A weight-loss alternative: Oxford Medical Products unveils new trial results for Sirona
As GLP-1 medications like Ozempic and Mounjaro dominate headlines, a new weight-loss solution is emerging for the millions left without viable options. Oxford Medical Products (OMP) has announced further positive results from its three-month clinical trials for Sirona, a breakthrough treatment targeting those classified as overweight (BMI 25-30) and those transitioning off GLP-1 drugs.
Hospitality data, a sustainable wearable and more in this week's MaddyMoney
Every week, Maddyness brings you the latest investment news from the UK startup ecosystem. Here's a recap of this week's investments.
